{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:32:42Z","timestamp":1767652362638,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jfo.2008.11.008","type":"journal-article","created":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T04:56:16Z","timestamp":1233809776000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Protocole de surveillance ophtalmologique des patients trait\u00e9s par antipalud\u00e9ens de synth\u00e8se ou par vigabatrin au long cours"],"prefix":"10.1016","volume":"32","author":[{"given":"I.","family":"Ingster-Moati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Orssaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2008.11.008_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archopht.1957.00930050463019","article-title":"Unusual ocular lesions in a case of systemic lupus eryhtematosus AMA","volume":"57","author":"Cambiaggi","year":"1957","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajo.2006.12.042","article-title":"Detection of early hydroxychloroquine retinal toxicity by ring ratio analysis of multifocal electroretinography","volume":"143","author":"Lyons","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archopht.125.6.775","article-title":"High-Speed Ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy","volume":"125","author":"Rodriguez-Padilla","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.survophthal.2007.04.001","article-title":"Missing the Bull's Eye","volume":"52","author":"Gilbert","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/archopht.125.11.1585-a","article-title":"Screening for hydroxychloroquine toxicity","volume":"125","author":"Bienfang","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archopht.125.9.1303-c","article-title":"Hydroxychloroquine dosages should be calculated using lean body mass","volume":"125","author":"Pautler","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s004170050016","article-title":"Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction","volume":"238","author":"Kellner","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/B:DOOP.0000018385.99215.0d","article-title":"Assessing hydroxychloroquine toxicity by the multifocal ERG","volume":"108","author":"Moschos","year":"2004","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib9","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archopht.122.7.973","article-title":"Multifocal electroretinographic evaluation of long-term hydroxychloroquine users","volume":"122","author":"Maturi","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajo.2005.05.046","article-title":"Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy","volume":"140","author":"Lai","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jfo.2008.11.008_bib11","first-page":"3531","article-title":"Fundus Autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine\/hydroxychloroquine","volume":"47","author":"Kellner","year":"2006","journal-title":"IOVS"},{"key":"10.1016\/j.jfo.2008.11.008_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0181-5512(06)73825-6","article-title":"Intoxication r\u00e9tinienne s\u00e9v\u00e8re aux anti-palud\u00e9ens de synth\u00e8se","volume":"29","author":"Ingster-Moati","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1076\/ceyr.28.4.277.27835","article-title":"Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy","volume":"28","author":"Mahon","year":"2004","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2008.11.008_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.revmed.2006.05.002","article-title":"Faut-il doser l\u2019hydroxychloroquine chez les patients lupiques\u00a0?","volume":"27","author":"Costedoat-Chalumeau","year":"2006","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"10.1016\/j.jfo.2008.11.008_bib15","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archopht.117.9.1262","article-title":"Hydroxychloroquine retinopathy","volume":"117","author":"Maturi","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib16","doi-asserted-by":"crossref","unstructured":"The Canadian Hydroxychloroquine Study Group A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991; 324:150\u20134.","DOI":"10.1056\/NEJM199101173240303"},{"issue":"314","key":"10.1016\/j.jfo.2008.11.008_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","article-title":"Severe persistent visual field constriction associated with vigabatrin","volume":"18","author":"Eke","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jfo.2008.11.008_bib18","first-page":"217","article-title":"Visual field defects with vigabatrin: epidemiology and therapeutic implications CNS","volume":"15","author":"Kalviainen","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jfo.2008.11.008_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/seiz.2001.0544","article-title":"Reversed visual field constrictions in children after vigabatrin withdrawal\u2013true retinal recovery or improved test performance only?","volume":"10","author":"Vanhatalo","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.jfo.2008.11.008_bib20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1167\/iovs.05-0854","article-title":"Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer","volume":"47","author":"Wild","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2008.11.008_bib21","first-page":"1075","article-title":"\u00c9tude du champ visuel et traitement par vigabatrin chez l\u2019enfant","volume":"24","author":"Pelosse","year":"2001","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2008.11.008_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1528-1157.2001.49299.x","article-title":"Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making","volume":"42","author":"Paul","year":"2001","journal-title":"Epilepsia"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551208000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551208000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T18:59:55Z","timestamp":1759258795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551208000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0181551208000144"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2008.11.008","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocole de surveillance ophtalmologique des patients trait\u00e9s par antipalud\u00e9ens de synth\u00e8se ou par vigabatrin au long cours","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2008.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}